Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

September 2020; Volume 40,Issue 9

Special Issue on New Anticancer Agents

Reviews

  • You have access
    The Role of the Microbiome in Cancer and Therapy Efficacy: Focus on Lung Cancer
    ADRIENNE HALLEY, ALESSANDRO LEONETTI, ALESSANDRO GREGORI, MARCELLO TISEO, DONG MEI DENG, ELISA GIOVANNETTI and GODEFRIDUS J. PETERS
    Anticancer Research September 2020, 40 (9) 4807-4818; DOI: https://doi.org/10.21873/anticanres.14484
  • You have access
    Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: Review of the Literature and Perspectives of Clinical Research
    ANGIOLO GADDUCCI and STEFANIA COSIO
    Anticancer Research September 2020, 40 (9) 4819-4828; DOI: https://doi.org/10.21873/anticanres.14485
  • You have access
    The Future of ER+/HER2− Metastatic Breast Cancer Therapy: Beyond PI3K Inhibitors
    ATHINA STRAVODIMOU and IOANNIS A. VOUTSADAKIS
    Anticancer Research September 2020, 40 (9) 4829-4841; DOI: https://doi.org/10.21873/anticanres.14486
  • You have access
    Inhibitors of Fatty Acid Synthesis and Oxidation as Potential Anticancer Agents in Colorectal Cancer Treatment
    PAULINA MOZOLEWSKA, KATARZYNA DUZOWSKA, ALICJA PAKIET, ADRIANA MIKA and TOMASZ ŚLEDZIŃSKI
    Anticancer Research September 2020, 40 (9) 4843-4856; DOI: https://doi.org/10.21873/anticanres.14487

Experimental Studies

  • You have access
    Targeting Membrane HDM-2 by PNC-27 Induces Necrosis in Leukemia Cells But Not in Normal Hematopoietic Cells
    ANUSHA THADI, LAUREN LEWIS, EVE GOLDSTEIN, ANSHU AGGARWAL, MARIAN KHALILI, LINDSAY STEELE, BORIS POLYAK, SHABNAM SEYDAFKAN, MARTIN H. BLUTH, KRISTINE A. WARD, MICHAEL STYLER, PAUL M. CAMPBELL, MATTHEW R. PINCUS and WILBUR B. BOWNE
    Anticancer Research September 2020, 40 (9) 4857-4867; DOI: https://doi.org/10.21873/anticanres.14488
  • You have access
    Adjuvant Oral Recombinant Methioninase Inhibits Lung Metastasis in a Surgical Breast-Cancer Orthotopic Syngeneic Model
    NORIHIKO SUGISAWA, KAZUYUKI HAMADA, QINGHONG HAN, JUN YAMAMOTO, YU SUN, HIROTO NISHINO, KEI KAWAGUCHI, MICHAEL BOUVET, MICHIAKI UNNO and ROBERT M. HOFFMAN
    Anticancer Research September 2020, 40 (9) 4869-4874; DOI: https://doi.org/10.21873/anticanres.14489
  • You have access
    A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell Carcinoma
    TAIGO KATO, EISUKE TOMIYAMA, YOKO KOH, MAKOTO MATSUSHITA, YUJIRO HAYASHI, KOSUKE NAKANO, YU ISHIZUYA, CONG WANG, KOJI HATANO, ATSUNARI KAWASHIMA, TAKESHI UJIKE, KEISUKE KAWASAKI, EIICHI MORII, KUNIHITO GOTOH, HIDETOSHI EGUCHI, KAZUMA KIYOTANI, KAZUTOSHI FUJITA, NORIO NONOMURA and MOTOHIDE UEMURA
    Anticancer Research September 2020, 40 (9) 4875-4883; DOI: https://doi.org/10.21873/anticanres.14490
  • You have access
    Antitumor Effects and Tumor-specificity of Guaiazulene-3-Carboxylate Derivatives Against Oral Squamous Cell Carcinoma In Vitro
    MICHITO TERATANI, SHOUTA NAKAMURA, HIROSHI SAKAGAMI, MASAKAZU FUJISE, MASASHI HASHIMOTO, NORIYUKI OKUDAIRA, KENJIRO BANDOW, YOSUKE IIJIMA, JUNKO NAGAI, YOSHIHIRO UESAWA and HIDETSUGU WAKABAYASHI
    Anticancer Research September 2020, 40 (9) 4885-4894; DOI: https://doi.org/10.21873/anticanres.14491
  • You have access
    Effect of Phosphoribosyltransferase Down-regulation on Malignant Glioma Cell Characteristics
    MINORI KAMADA, KEIICHI IKEDA and YOSHINOBU MANOME
    Anticancer Research September 2020, 40 (9) 4895-4905; DOI: https://doi.org/10.21873/anticanres.14492
  • You have access
    Luteolin Induces Cytotoxicity in Mix Cellularity Classical Hodgkin's Lymphoma via Caspase Activated-cell Death
    RAJENDRA GHARBARAN, ENYUAN SHANG, ONYEKWERE ONWUMERE, NAOMI CODRINGTON, EVANGELINA DANKWA SARPONG and STEPHEN REDENTI
    Anticancer Research September 2020, 40 (9) 4907-4912; DOI: https://doi.org/10.21873/anticanres.14493
  • You have access
    New Imidazo[2,1-b][1,3,4]Thiadiazole Derivatives Inhibit FAK Phosphorylation and Potentiate the Antiproliferative Effects of Gemcitabine Through Modulation of the Human Equilibrative Nucleoside Transporter-1 in Peritoneal Mesothelioma
    GIOVANNA LI PETRI, CAMILLA PECORARO, ORNELLA RANDAZZO, SILVIA ZOPPI, STELLA MARIA CASCIOFERRO, BARBARA PARRINO, DANIELA CARBONE, BTISSAME EL HASSOUNI, ANDREA CAVAZZONI, NADIA ZAFFARONI, GIROLAMO CIRRINCIONE, PATRIZIA DIANA, GODEFRIDUS J. PETERS and ELISA GIOVANNETTI
    Anticancer Research September 2020, 40 (9) 4913-4919; DOI: https://doi.org/10.21873/anticanres.14494
  • You have access
    Phenothiazines and Selenocompounds: A Potential Novel Combination Therapy of Multidrug Resistant Cancer
    MÁRIÓ GAJDÁCS, MÁRTA NOVÉ, ÁKOS CSONKA, BORISZ VARGA, CARMEN SANMARTÍN, ENRIQUE DOMÍNGUEZ-ÁLVAREZ and GABRIELLA SPENGLER
    Anticancer Research September 2020, 40 (9) 4921-4928; DOI: https://doi.org/10.21873/anticanres.14495
  • You have access
    Discovery of a Novel Chemical Scaffold Against Mutant Isocitrate Dehydrogenase 1 (IDH1)
    CHUNG HYO KANG, SANG UN CHOI, YOU HWA SON, HEUNG KYOUNG LEE, HYE GWANG JEONG, CHANG-SOO YUN, SUNJOO AHN and CHI HOON PARK
    Anticancer Research September 2020, 40 (9) 4929-4935; DOI: https://doi.org/10.21873/anticanres.14496
  • You have access
    ALK Inhibitors Do Not Increase Sensitivity to Radiation in EML4-ALK Non-small Cell Lung Cancer
    KATHRIN FLESCHUTZ, LISA WALTER, RUMO LEISTNER and LUCIE HEINZERLING
    Anticancer Research September 2020, 40 (9) 4937-4946; DOI: https://doi.org/10.21873/anticanres.14497
  • You have access
    Effects of Sclareol Against Small Cell Lung Carcinoma and the Related Mechanism: In Vitro and In Vivo Studies
    HSIANG LAI CHEN, JINY YIN GONG, SHIH-CHAO LIN, SHIMING LI, YU-CHIH CHIANG, JUI-HSIANG HUNG, CHIEH-CHI YEN and CHI-CHIEN LIN
    Anticancer Research September 2020, 40 (9) 4947-4960; DOI: https://doi.org/10.21873/anticanres.14498
  • You have access
    Inhibition of Retinoblastoma Cell Growth by CEP1347 Through Activation of the P53 Pathway
    KEITA TOGASHI, MASASHI OKADA, SHUHEI SUZUKI, TOMOMI SANOMACHI, SHIZUKA SEINO, MASAHIRO YAMAMOTO, HIDETOSHI YAMASHITA and CHIFUMI KITANAKA
    Anticancer Research September 2020, 40 (9) 4961-4968; DOI: https://doi.org/10.21873/anticanres.14499
  • You have access
    Brucea javanica Increases Survival and Enhances Gemcitabine Efficacy in a Patient-derived Orthotopic Xenograft (PDOX) Mouse Model of Pancreatic Cancer
    HAITAO YANG, ZHONG TONG, LEI SHEN, YU SUN, ROBERT M. HOFFMAN and JUN HUANG
    Anticancer Research September 2020, 40 (9) 4969-4978; DOI: https://doi.org/10.21873/anticanres.14500
  • You have access
    CDKN1A Gene Expression in Two Multiple Myeloma Cell Lines With Different P53 Functionality
    DENISA HRCKOVA DROZDKOVA, JAN GURSKY, JIRI MINARIK, IVO ÜBERALL, ZDENEK KOLAR and KATERINA SMESNY TRTKOVA
    Anticancer Research September 2020, 40 (9) 4979-4987; DOI: https://doi.org/10.21873/anticanres.14501
  • You have access
    Ephemeranthol A Suppresses Epithelial to Mesenchymal Transition and FAK-Akt Signaling in Lung Cancer Cells
    NONGYAO NONPANYA, ORNJIRA PRAKHONGCHEEP, KORRAKOD PETSRI, CHOLASIT JITJAICHAM, SUCHARAT TUNGSUKRUTHAI, BOONCHOO SRITULARAK and PITHI CHANVORACHOTE
    Anticancer Research September 2020, 40 (9) 4989-4999; DOI: https://doi.org/10.21873/anticanres.14502
  • You have access
    The Effects of Newly Synthesized Platinum(IV) Complexes on Cytotoxicity and Radiosensitization of Human Tumour Cells In Vitro
    MARIJA PETROVIC, SUZANA POPOVIC, DEJAN BASKIC, MILOS TODOROVIC, PREDRAG DJURDJEVIC, ALEKSANDRA RISTIC-FIRA, OTILIJA KETA, VLADANA PETKOVIC, LELA KORICANAC, DANIJELA STOJKOVIC, VERICA JEVTIC, SRECKO TRIFUNOVIC and DANIJELA TODOROVIC
    Anticancer Research September 2020, 40 (9) 5001-5013; DOI: https://doi.org/10.21873/anticanres.14503
  • You have access
    Assessment of In Vitro Anti-melanoma Potential of Ephedranthus pisocarpus R.E.Fr.
    LUBNA KARINE BESERRA SANTOS, MÁRCIA DENISE ALVES VERAS, KARINNE KELLY GADELHA MARQUES, MICHEL MUALÉM DE MORAES ALVES, ANDERSON NOGUEIRA MENDES, FERNANDO AÉCIO DE AMORIM CARVALHO, MARIANNA VIEIRA SOBRAL, MARIANA HELENA CHAVES and JUAN CARLOS RAMOS GONÇALVES
    Anticancer Research September 2020, 40 (9) 5015-5024; DOI: https://doi.org/10.21873/anticanres.14504
  • You have access
    A New Ciprofloxacin-derivative Inhibits Proliferation and Suppresses the Migration Ability of HeLa Cells
    MOUSTAFA FATHY, SIJIA SUN, QING-LI ZHAO, MOHAMED ABDEL-AZIZ, GAMAL EL-DIN A. ABUO-RAHMA, SURESH AWALE and TOSHIO NIKAIDO
    Anticancer Research September 2020, 40 (9) 5025-5033; DOI: https://doi.org/10.21873/anticanres.14505
  • You have access
    Up-regulation of Death Receptor 5/TRAIL-R2 Mediates Apoptosis Induced by N,N’-[(3,4-dimethoxyphenyl)methylene] Biscinnamide in Cancer Cells
    HIROMI II, SUSUMU NAKATA and JUN'ICHI UENISHI
    Anticancer Research September 2020, 40 (9) 5035-5041; DOI: https://doi.org/10.21873/anticanres.14506
  • You have access
    Inhibitory Effect of Eicosapentaenoic Acid on the Migration of the Esophageal Squamous Cell Carcinoma Cell Line TE-1
    HISAKO KUBOTA, TOSHIHIRO HIRAI, AKIRA YAMAUCHI, AYAKO OGO, HIDEO MATSUMOTO and TOMIO UENO
    Anticancer Research September 2020, 40 (9) 5043-5048; DOI: https://doi.org/10.21873/anticanres.14507
  • You have access
    Anticancer Effect of a Spiro-acridine Compound Involves Immunomodulatory and Anti-angiogenic Actions
    SÂMIA SOUSA DUARTE, DAIANA KARLA FRADE SILVA, THAÍS MANGEON HONORATO LISBOA, RAWNY GALDINO GOUVEIA, RAFAEL CARLOS FERREIRA, RICARDO OLÍMPIO DE MOURA, JAMIRE MURIEL DA SILVA, ÉSSIA DE ALMEIDA LIMA, SANDRA RODRIGUES-MASCARENHAS, PATRICIA MIRELLA DA SILVA, DAVI FELIPE FARIAS, JULIANA ALVES DA COSTA RIBEIRO SOUZA, KARINA CARLA DE PAULA MEDEIROS, JUAN CARLOS RAMOS GONÇALVES and MARIANNA VIEIRA SOBRAL
    Anticancer Research September 2020, 40 (9) 5049-5057; DOI: https://doi.org/10.21873/anticanres.14508
  • You have access
    Cetyltrimethylammonium Bromide Suppresses the Migration and Invasion of Hepatic Mahlavu Cells by Modulating Fibroblast Growth Factor Signaling
    TSAI-KUN WU, CHUNG-HUNG CHEN, WEI-TING LEE, TZU-FEN SU, YING-RU PAN, FU-MEI HUANG and CHIA-JEN LEE
    Anticancer Research September 2020, 40 (9) 5059-5069; DOI: https://doi.org/10.21873/anticanres.14509
  • You have access
    Setanaxib as a Potent Hypoxia-specific Therapeutic Agent Against Liver Cancer
    SATOSHI OWADA, HITOSHI ENDO, CHISA OKADA, KAZUHIRO YOSHIDA, YUKARI SHIDA and MASAYUKI TATEMICHI
    Anticancer Research September 2020, 40 (9) 5071-5079; DOI: https://doi.org/10.21873/anticanres.14510
  • You have access
    Novel Imidazo[2,1-b]oxazole Derivatives Inhibit Epithelial Cell Transformation and Triple Negative Breast Cancer Tumorigenesis
    POSHAN YUGAL BHATTARAI, CHANG-HYUN OH, GARAM KIM, MIN SOO KIM, BONG SANG LEE and HONG SEOK CHOI
    Anticancer Research September 2020, 40 (9) 5081-5090; DOI: https://doi.org/10.21873/anticanres.14511
  • You have access
    YM155 Reverses Cabazitaxel Resistance in Castration-resistant Prostate Cancer by Reducing Survivin Expression
    TAKESHI MIYAO, HIDEKAZU KOIKE, YOSHITAKA SEKINE, AKIRA OHTSU, DAISUKE OKA and KAZUHIRO SUZUKI
    Anticancer Research September 2020, 40 (9) 5091-5095; DOI: https://doi.org/10.21873/anticanres.14512
  • You have access
    Assessing the Anti-cancer Therapeutic Mechanism of a Herbal Combination for Breast Cancer on System-level by a Network Pharmacological Approach
    HO-SUNG LEE and DAL-SEOK OH
    Anticancer Research September 2020, 40 (9) 5097-5106; DOI: https://doi.org/10.21873/anticanres.14513
  • You have access
    Anti-tumor Effect of Hedgehog Signaling Inhibitor, Vismodegib, on Castration-resistant Prostate Cancer
    AYA ISHII, KATSUMI SHIGEMURA, KOICHI KITAGAWA, SHIAN-YING SUNG, KUAN-CHOU CHEN, CHIANG YI-TE, MING-CHE LIU and MASATO FUJISAWA
    Anticancer Research September 2020, 40 (9) 5107-5114; DOI: https://doi.org/10.21873/anticanres.14514
  • You have access
    Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines
    UNCHALEE THONSRI, WUNCHANA SEUBWAI, SAKDA WARAASAWAPATI, SOPIT WONGKHAM, THIDARAT BOONMARS, UBON CHA'ON and CHAISIRI WONGKHAM
    Anticancer Research September 2020, 40 (9) 5115-5124; DOI: https://doi.org/10.21873/anticanres.14515
  • You have access
    Anti-progressive Effects of a Series of Glycinyl and Alaninyl Triazolyl-oxazolidinones on Kelly Neuroblastoma Cell Line
    NADA A. AL-HASAWI, OLUDOTUN A. PHILLIPS, FATMA AL-AWADHI, LEYLA H. SHARAF, SANAA A. AMINE and LADISLAV NOVOTNY
    Anticancer Research September 2020, 40 (9) 5125-5140; DOI: https://doi.org/10.21873/anticanres.14516
  • You have access
    Temozolomide and AZD7762 Induce Synergistic Cytotoxicity Effects on Human Glioma Cells
    YUN CHEN, BOR-JIUN TSENG, YA-HUI TSAI and SHENG-HONG TSENG
    Anticancer Research September 2020, 40 (9) 5141-5149; DOI: https://doi.org/10.21873/anticanres.14517
  • You have access
    Static Magnetic Stimulation Induces Cell-type Specific Alterations in the Viability of SH-SY5Y Neuroblastoma Cell Line
    HELOUISE R. MEDEIROS, JOSÉ A. F. ASSUMPCAO, LICIANE F. MEDEIROS, MARTINA STAPENHORST, LARA NUNES, NICOLE A.C. HENCKES, CAROLINA URIBE CRUZ, FELIPE FREGNI, PAULO R.S. SANCHES, FERNANDA S.O. OLIVEIRA, WOLNEI CAUMO, ELIZABETH O. CIRNE-LIMA and IRACI L.S. TORRES
    Anticancer Research September 2020, 40 (9) 5151-5158; DOI: https://doi.org/10.21873/anticanres.14518
  • You have access
    Redox-related Molecular Mechanism of Sensitizing Colon Cancer Cells to Camptothecin Analog SN38
    BILIANA NIKOLOVA, SEVERINA SEMKOVA, IANA TSONEVA, ELENA STOYANOVA, PAVEL LEFTEROV, DESSISLAVA LAZAROVA, ZHIVKO ZHELEV, ICHIO AOKI, TATSUYA HIGASHI and RUMIANA BAKALOVA
    Anticancer Research September 2020, 40 (9) 5159-5170; DOI: https://doi.org/10.21873/anticanres.14519
  • You have access
    Inhibitory Effects of Beraprost Sodium in Murine Hepatic Sinusoidal Obstruction Syndrome
    MAKOTO NAKURA, TOMOHARU MIYASHITA, YASUHIKO YAMAMOTO, SATOSHI TAKADA, SHUNSUKE KANOU, HIDEHIRO TAJIMA, HIROYUKI TAKAMURA and TETSUO OHTA
    Anticancer Research September 2020, 40 (9) 5171-5180; DOI: https://doi.org/10.21873/anticanres.14520
  • You have access
    Advanced Non-linear Mathematical Model for the Prediction of the Activity of a Putative Anticancer Agent in Human-to-mouse Cancer Xenografts
    SOTIRIOS G. LILIOPOULOS, GEORGE S. STAVRAKAKIS and KONSTANTINOS S. DIMAS
    Anticancer Research September 2020, 40 (9) 5181-5189; DOI: https://doi.org/10.21873/anticanres.14521
  • You have access
    Methylsulfonylmethane Induces Cell Cycle Arrest and Apoptosis, and Suppresses the Stemness Potential of HT-29 Cells
    DOH HOON KIM, DONG YOUNG KANG, NIPIN SP, EUN SEONG JO, ALEXIS RUGAMBA, KYOUNG-JIN JANG and YOUNG MOK YANG
    Anticancer Research September 2020, 40 (9) 5191-5200; DOI: https://doi.org/10.21873/anticanres.14522
  • You have access
    Total Flavonoids Isolated from Diospyros kaki L. f. Leaves Induced Apoptosis and Oxidative Stress in Human Cancer Cells
    LI CHEN, YUHANG GUO, GHEDA ALSAIF and YING GAO
    Anticancer Research September 2020, 40 (9) 5201-5210; DOI: https://doi.org/10.21873/anticanres.14523
  • You have access
    Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against β-Catenin-activated Hepatocellular Carcinoma
    RYOSUKE GABATA, KENICHI HARADA, YUKI MIZUTANI, HIROFUMI OUCHI, KAORI YOSHIMURA, YASUNORI SATO, AZUSA KITAO, KIMINORI KIMURA, HIROYUKI KOUJI, TOMOHARU MIYASHITA, HIDEHIRO TAJIMA and TETSUO OHTA
    Anticancer Research September 2020, 40 (9) 5211-5219; DOI: https://doi.org/10.21873/anticanres.14524
  • You have access
    Gamma/Delta T-Cells Enhance Carboplatin-induced Cytotoxicity Towards Advanced Bladder Cancer Cells
    YUEH PAN, YA-HSU CHIU, SHAO-CHIH CHIU, DER-YANG CHO, LIANG-MING LEE, YU-CHING WEN, JACQUELINE WHANG-PENG, CHI-HAO HSIAO and PING-HSIAO SHIH
    Anticancer Research September 2020, 40 (9) 5221-5227; DOI: https://doi.org/10.21873/anticanres.14525

Clinical Studies

  • You have access
    Phase I Study of LFA102 in Patients With Advanced Breast Cancer or Castration-resistant Prostate Cancer
    HIRONOBU MINAMI, YUICHI ANDO, KENJI TAMURA, TAKESHI TAJIMA and RANDI ISAACS
    Anticancer Research September 2020, 40 (9) 5229-5235; DOI: https://doi.org/10.21873/anticanres.14526
  • You have access
    Mogamulizumab Plus EPOCH Therapy for Patients With Newly Diagnosed Aggressive Adult T-cell Leukemia/lymphoma
    TATSURO JO, KAORI MATSUZAKA, HARUNA SHIOYA, HIROO TOMINAGA, TAKAHIRO SAKAI, YOHEI KANEKO, SHIZUKA HAYASHI, MASATOSHI MATSUO, JUN TAGUCHI, KUNIKO ABE, KAZUTO SHIGEMATSU and RITSUKO KUBOTA-KOKETSU
    Anticancer Research September 2020, 40 (9) 5237-5243; DOI: https://doi.org/10.21873/anticanres.14527
  • You have access
    Higher BMI, But Not Sarcopenia, Is Associated With Pembrolizumab-related Toxicity in Patients With Advanced Melanoma
    JANICE B. HU, SURYA RAVICHANDRAN, CHRISTEL RUSHING, GEORGIA M. BEASLEY, BRENT A. HANKS, SIN-HO JUNG, APRIL K.S. SALAMA, LISA HO and PAUL J. MOSCA
    Anticancer Research September 2020, 40 (9) 5245-5254; DOI: https://doi.org/10.21873/anticanres.14528
  • You have access
    Cabazitaxel - A Treatment Option in Recurrent Platinum-resistant Ovarian Cancer
    CHRISTINE VESTERGAARD MADSEN, PARVIN ADIMI, ANDERS JAKOBSEN and KARINA DAHL STEFFENSEN
    Anticancer Research September 2020, 40 (9) 5255-5261; DOI: https://doi.org/10.21873/anticanres.14529
  • You have access
    Successful Management of Platinum-resistant Ovarian Cancer by Weekly Nedaplatin Followed by Olaparib: Three Case Reports
    SHU SOEDA, TAKAFUMI WATANABE, NORIHITO KAMO, TETSU SATO, CHIKAKO OKABE, MAKIKO UEDA, YUTA ENDO, KOJIMA MANABU, SHINJI NOMURA, SHIGENORI FURUKAWA, HIDEKAZU NISHIGORI, TOSHIFUMI TAKAHASHI and KEIYA FUJIMORI
    Anticancer Research September 2020, 40 (9) 5263-5270; DOI: https://doi.org/10.21873/anticanres.14530
  • You have access
    Factors Raising Serum Ammonia Level During Lenvatinib Treatment of Patients With Hepatocellular Carcinoma
    RYOICHI NARITA, KAZUHIRO KOTOH, AKITOSHI YONEDA, MITSUTERU MOTOMURA and MASARU HARADA
    Anticancer Research September 2020, 40 (9) 5271-5276; DOI: https://doi.org/10.21873/anticanres.14531
  • You have access
    Salvage Chemotherapy After Nivolumab for Recurrent or Metastatic Head and Neck Carcinoma
    CHIHIRO FUSHIMI, ISAKU OKAMOTO, TAKASHI MATSUKI, TATSUO MASUBUCHI, TAKURO OKADA, HIROKI SATO, KIYOAKI TSUKAHARA, TAKAHITO KONDO, TAKU YAMASHITA, KENJI HANYU, GO OMURA, HIDEAKI TAKAHASHI, YUICHIRO TADA and KOUKI MIURA
    Anticancer Research September 2020, 40 (9) 5277-5283; DOI: https://doi.org/10.21873/anticanres.14532
  • You have access
    Continuous Administration of Bevacizumab After Disease Progression in Recurrent Ovarian Cancer: A Retrospective Observational Study
    TERUMI TANIGAWA, MAKI MATODA, MAKIKO OMI, YOICHI AOKI, SACHIHO NETSU, HIDETAKA NOMURA, SANSHIRO OKAMOTO, KOHEI OMATSU, MAYU YUNOKAWA, HIROYUKI KANAO and NOBUHIRO TAKESHIMA
    Anticancer Research September 2020, 40 (9) 5285-5290; DOI: https://doi.org/10.21873/anticanres.14533
  • You have access
    Severe Gastrointestinal Mucositis Following Concurrent Palbociclib and Palliative Radiation Therapy
    UMAIR M. NASIR, ALEXANDER M. MOZEIKA, MUTLAY SAYAN, IMRAAN JAN, NOEL KOWAL, BRUCE HAFFTY, SUSHIL AHLAWAT and NEIL KOTHARI
    Anticancer Research September 2020, 40 (9) 5291-5294; DOI: https://doi.org/10.21873/anticanres.14534
  • You have access
    Randomized Study of Postoperative Single Intravesical Instillation With Pirarubicin and Mitomycin C for Low-risk Bladder Cancer
    SHINYA YAMAMOTO, YUKIO KAGEYAMA, YASUHISA FUJII, TAKU AIZAWA, SHINJI URAKAMI and IWAO FUKUI
    Anticancer Research September 2020, 40 (9) 5295-5299; DOI: https://doi.org/10.21873/anticanres.14535
  • You have access
    Phase I Study of the Administration of Low-dose Perioperative Human Atrial Natriuretic Peptide in Patients With Resectable Colorectal Cancer
    HIDEKAZU TAKAHASHI, TAKASHI TAKEDA, YUJIRO NISHIZAWA, TAKAYUKI OGINO, NORIKATSU MIYOSHI, CHU MATSUDA, HIROFUMI YAMAMOTO, TSUNEKAZU MIZUSHIMA, YUICHIRO DOKI and HIDETOSHI EGUCHI
    Anticancer Research September 2020, 40 (9) 5301-5307; DOI: https://doi.org/10.21873/anticanres.14536
  • You have access
    Recovery of the Sensitivity to Anti-PD-1 Antibody by Celecoxib in Lung Cancer
    KUNIHIKO KOBAYASHI, KYOICHI KAIRA and HIROSHI KAGAMU
    Anticancer Research September 2020, 40 (9) 5309-5311; DOI: https://doi.org/10.21873/anticanres.14537
  • You have access
    Second-line Dasatinib Therapy Improved Compliance and Deep Molecular Responses in Imatinib-intolerant Chronic Myeloid Leukemia Patients
    UROS MARKOVIC, ANNA BULLA, SALVATORE LEOTTA, STEFANIA STELLA, MARIA LETIZIA CONSOLI, LOREDANA TAMBÈ, CONCETTA CONTICELLO, FRANCESCO DI RAIMONDO and FABIO STAGNO
    Anticancer Research September 2020, 40 (9) 5313-5317; DOI: https://doi.org/10.21873/anticanres.14538
  • You have access
    Clinical Outcome of Surgically Treated Leiomyosarcoma of the Extremities: A Retrospective Overview
    ANNELIES VAN BEECK, MICHIEL VAN DE SANDE, VERONIEK VAN PRAAG, DIETMAR DAMMERER, JOZEF MICHIELSEN, THOMAS SCHUBERT, BILAL KAPANCI, FELIX SHUMELINSKY, JOHAN SOMVILLE and SANDER DIJKSTRA
    Anticancer Research September 2020, 40 (9) 5319-5325; DOI: https://doi.org/10.21873/anticanres.14539

Erratum

  • You have access
    Erratum
    Anticancer Research September 2020, 40 (9) 5327;
Back to top
PreviousNext

In this issue

Anticancer Research: 40 (9)
Anticancer Research
Vol. 40, Issue 9
September 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Erratum
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire